Shami Patel
CIK: 0001378251
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CERO THERAPEUTICS HOLDINGS, INC.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jan 7, 2026CERO
CERO THERAPEUTICS HOLDINGS, INC.
Award(A)DirectStock Option (Right to Buy)
690.9K shares- - May 30, 2025CERO
CERO THERAPEUTICS HOLDINGS, INC.
Award(A)DirectStock Option (Right to Buy)
11.7K shares- - Mar 4, 2025CERO
CERO THERAPEUTICS HOLDINGS, INC.
Award(A)DirectStock Option (Right to Buy)
14.9K shares- - Feb 24, 2025CERO
CERO THERAPEUTICS HOLDINGS, INC.
Award(A)DirectStock Option (Right to Buy)
127.5K shares- - Dec 2, 2024CERO
CERO THERAPEUTICS HOLDINGS, INC.
Award(A)DirectStock Option (Right to Buy)
127.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 7, 2026 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Award(A) Stock Option (Right to Buy) | 690,900 | - | - | Direct |
| May 30, 2025 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Award(A) Stock Option (Right to Buy) | 11,693 | - | - | Direct |
| Mar 4, 2025 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Award(A) Stock Option (Right to Buy) | 14,936 | - | - | Direct |
| Feb 24, 2025 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Award(A) Stock Option (Right to Buy) | 127,500 | - | - | Direct |
| Dec 2, 2024 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Award(A) Stock Option (Right to Buy) | 127,500 | - | - | Direct |
1-5 of 5 transactions
About Patel Shami
Patel Shami (SEC CIK 0001378251) files insider reports with the SEC as Director of CERO THERAPEUTICS HOLDINGS, INC. (CERO).
Signal8 holds 6 ownership filings by Patel Shami (1 Form 3, 5 Form 4), filed between Oct 11, 2024 and Jan 9, 2026. Those filings report 5 transactions, from Dec 2, 2024 to Jan 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Patel Shami's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Patel Shami
- Jan 7, 2026: Grant or award of CERO derivative securities (Form 4, code A).
- May 30, 2025: Grant or award of CERO derivative securities (Form 4, code A).
- Mar 4, 2025: Grant or award of CERO derivative securities (Form 4, code A).
- Feb 24, 2025: Grant or award of CERO derivative securities (Form 4, code A).
- Dec 2, 2024: Grant or award of CERO derivative securities (Form 4, code A).
Other insiders filing for CERO THERAPEUTICS HOLDINGS, INC. (CERO)
- Francois Eric, Director
- Rolfe Lindsey, Director
- LAPORTE KATHLEEN, Director
- Pierce Kristen, Chief Development Officer
- ATWOOD BRIAN G, Director
- Ehrlich Christopher B, Chairman and CEO